Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
AKAP13 is a protein that integrates various signaling such as mechanical stress and estrogen receptor activation. Analyses of animal and osteoblastic cells revealed that AKAP13 is involved in bone formation. AKAP13 plays an important role in the early stages of differentiation of osteoblasts, according to the expression analysis of the AKAP13 mRNA during differentiation of osteoblasts for bone formation, suggesting that AKAP13 may be an initiation trigger for osteogenic function and bone remodeling. We believe that analysis of AKAP13 and co-factor will lead to the development of new osteoporosis drugs the future.
|